Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study (CALIPSO): multicentre, adaptive, double-blind, three-arm, placebo-controlled, non-inferiority trial examining antimicrobial prophylaxis duration in cardiac surgery

Peel, Trisha (Primary Chief Investigator (PCI))
Myles, Paul (Chief Investigator (CI))
McGiffin, David (Chief Investigator (CI))
Smith, Julian (Chief Investigator (CI))
Forbes, Andrew (Chief Investigator (CI))
Marasco, Silvana (Chief Investigator (CI))
Pilcher, David (Chief Investigator (CI))
Stewardson, Andrew (Chief Investigator (CI))
Petrie, Dennis (Chief Investigator (CI))
Peleg, Anton (Chief Investigator (CI))
Wisniewski, Jessica (Associate Investigator (AI))
Russo, Philip (Associate Investigator (AI))
Forster, Sam (Associate Investigator (AI))

Project: Research

1 Article

1 results

2024

Healthcare-associated infections and antimicrobial use at a major referral hospital in Papua New Guinea: a point prevalence survey
Curtis, S. J. (Leading Author), Barnabas, R., Cairns, K. A., Cameron, D., Coghlan, B., Jones, R., Joseph, J., Kali, A., Kep, D., Klintworth, G., Levy, S., Mason, M., Norrie, M., Peel, T., Tamolsaian, G., Telenge, J., Tumu, N., Stewardson, A. J. (Leading Author), Ak, G. (Leading Author) & the COMBAT-AMR group, Jul 2024, In: The Lancet Regional Health - Western Pacific. 48, 9 p., 101120.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

3 Citations (Scopus)